In light of this information, we examined the expression of MMP 3/10 in control and MortaparibMild-treated cells and found decrease in the latter (Figure 6B) suggesting it as one of the p53-independent mechanisms involved in MortaparibMild-mediated decrease in cancer cell migration. This evidence concerns the gene TP53 and cancer.